183 related articles for article (PubMed ID: 26097553)
1. HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 production.
Zhao Y; Sun Y; Zhang H; Liu X; Du W; Li Y; Zhang J; Chen L; Jiang C
Int J Clin Exp Pathol; 2015; 8(4):3719-26. PubMed ID: 26097553
[TBL] [Abstract][Full Text] [Related]
2. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
3. Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE2 pathway.
Li Z; You K; Li J; Wang Y; Xu H; Gao B; Wang J
Int Immunopharmacol; 2016 Apr; 33():24-32. PubMed ID: 26851630
[TBL] [Abstract][Full Text] [Related]
4. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
[TBL] [Abstract][Full Text] [Related]
5. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
[TBL] [Abstract][Full Text] [Related]
6. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathway involved in cyclooxygenase-2 up-regulation by hepatocyte growth factor in endometrial cancer cells.
Yoshizawa Y; Yamada Y; Kanayama S; Shigetomi H; Kawaguchi R; Yoshida S; Nagai A; Furukawa N; Oi H; Kobayashi H
Oncol Rep; 2011 Oct; 26(4):957-64. PubMed ID: 21687953
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
[TBL] [Abstract][Full Text] [Related]
9. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Garnett J; Chumbalkar V; Vaillant B; Gururaj AE; Hill KS; Latha K; Yao J; Priebe W; Colman H; Elferink LA; Bogler O
Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
[TBL] [Abstract][Full Text] [Related]
10. Interaction of apoptotic cells with macrophages upregulates COX-2/PGE2 and HGF expression via a positive feedback loop.
Byun JY; Youn YS; Lee YJ; Choi YH; Woo SY; Kang JL
Mediators Inflamm; 2014; 2014():463524. PubMed ID: 24959005
[TBL] [Abstract][Full Text] [Related]
11. MET in glioma: signaling pathways and targeted therapies.
Cheng F; Guo D
J Exp Clin Cancer Res; 2019 Jun; 38(1):270. PubMed ID: 31221203
[TBL] [Abstract][Full Text] [Related]
12. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
Siegfried JM; Gubish CT; Rothstein ME; Queiroz de Oliveira PE; Stabile LP
Mol Pharmacol; 2007 Sep; 72(3):769-79. PubMed ID: 17550984
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.
Zhang A; Wang MH; Dong Z; Yang T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1323-31. PubMed ID: 16868306
[TBL] [Abstract][Full Text] [Related]
14. MiR-410 regulates MET to influence the proliferation and invasion of glioma.
Chen L; Zhang J; Feng Y; Li R; Sun X; Du W; Piao X; Wang H; Yang D; Sun Y; Li X; Jiang T; Kang C; Li Y; Jiang C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1711-7. PubMed ID: 22750473
[TBL] [Abstract][Full Text] [Related]
15. Targeting MET for glioma therapy.
Awad AJ; Burns TC; Zhang Y; Abounader R
Neurosurg Focus; 2014 Dec; 37(6):E10. PubMed ID: 25434379
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
Qiu J; Li Q; Bell KA; Yao X; Du Y; Zhang E; Yu JJ; Yu Y; Shi Z; Jiang J
Br J Pharmacol; 2019 Jun; 176(11):1680-1699. PubMed ID: 30761522
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
Li Y; Fan X; Goodwin CR; Laterra J; Xia S
BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
[TBL] [Abstract][Full Text] [Related]
18. HGF/MET Signaling in Malignant Brain Tumors.
Mulcahy EQX; Colόn RR; Abounader R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066121
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
20. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor.
Chen JH; Wu CW; Kao HL; Chang HM; Li AF; Liu TY; Chi CW
Cancer Lett; 2006 Aug; 239(2):263-70. PubMed ID: 16243430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]